Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
According to a report, about 55% of commercial employers currently cover GLP-1s for obesity, but 15% of those have dropped coverage due to unsustainable costs
A CMS payment demonstration is expanding access for Medicare and Medicaid beneficiaries at reduced costs beginning mid-2026
In addition, Astragaloside IV treatment also ameliorates urinary albumin excretion and kidney injury in db/db mice (Liu et al., 2017)
PMC 6079408
US$ 20.53
US$ 27.85
US$ 25.95
US$ 21.12
US$ 21.90
